Indication:Cancer patients receiving myelosuppressive chemotherapy or bone marrow transplant to decrease the incidence of infection and patients with neutropenia.

Specification:300mcg/vial, 150mcg/vial, 75mcg/vial

Dosage Form:Injection

Active Ingredients:rhG-CSF

Route of Administration:Subcutaneous Injection

Shelf Life:3 years

Storage:2℃-8℃

Package:5vials/box

Place of Origin:china

Qualification:Chinese GMP

CAS:100

Indication:OPDIVO® (nivolumab) is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy.

Specification:to be administered by hospital or qualified physician only

Dosage Form:Injection

Active Ingredients:NIVOLUMAB

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:2℃-8℃

Package:1 VIAL per pack

Place of Origin:EU

Qualification:EU GMP

Indication:PegLeukim is indicated to decrease the incidence of infection as manifested by neutropenia in patients with malignancies receiving myelosuppression anti-cancer drugs associated with a significant inci

Specification:3mg/vial

Dosage Form:Injection

Active Ingredients:peg-rhG-CSF

Route of Administration:Subcutaneous Injection

Shelf Life:3 years

Storage:2℃-8℃

Package:1vial/box

Place of Origin:China

Qualification:Chinese GMP

Indication:Symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.

Dosage Form:Tablet

Active Ingredients:Vandetanib 100mg, 300mg, tabs.

Route of Administration:Oral

Shelf Life:18 months

Storage:Below 30℃

Package:30 TAB PER BOTTLE

Place of Origin:EU

Qualification:EU GMP

Indication:Treatment of adults with chronic, accelerated, or blast phase chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) for whom no other tyrosine kinas

Dosage Form:Tablet

Active Ingredients:Pontinib

Route of Administration:Oral

Shelf Life:18 months

Storage:Below 30℃

Package:30 Or 90 Film Coated Tablets

Place of Origin:EU

Qualification:EU GMP

Dosage Form:Injection

Route of Administration:Intramuscular Injection

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Indication:Lung cancer

Dosage Form:Tablet

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Qualification:FDA

Dosage Form:Capsule

Route of Administration:Oral

Shelf Life:2 years

Storage:Sealed

Place of Origin:China

Specification:50mg, 100mg

Dosage Form:Powder

Active Ingredients:oxaliplatin

Route of Administration:Intravenous Drip

Shelf Life:2 years

Storage:Protected from light

Package:Negotiable

Qualification:Chinese GMP

Specification:0.2g, 1.0g

Dosage Form:Powder

Active Ingredients:gemcitabine hydrochloride

Route of Administration:Intravenous Drip

Shelf Life:2 years

Storage:Protected from light

Package:Negotiable

Qualification:Chinese GMP

Dosage Form:Injection

Route of Administration:Oral

Shelf Life:18 months

Storage:Sealed

Qualification:Chinese GMP

CAS:1032900-25-6

Dosage Form:Injection

Route of Administration:Oral

Shelf Life:18 months

Storage:Sealed

Qualification:Chinese GMP

Specification:10000iu/ vial

Dosage Form:Injection

Active Ingredients:L-asparaginase(Erwinia)

Route of Administration:Oral

Shelf Life:18 months

Storage:Sealed

Package:vial

Place of Origin:China

Qualification:Chinese GMP

Indication:Approved indications (China) ：Metastatic Colorectal Cancer （mCRC）; Advanced, Recurrent or Metastatic Non– Small Cell Lung Cancer （NSCLC） Indications under Application (China) : Recurrent glioblastom

Specification:100mg/4ml

Dosage Form:Injection

Active Ingredients:bevacizumab

Route of Administration:Oral

Shelf Life:2 years

Storage:2℃-8℃

Package:vial

Place of Origin:China

Qualification:Chinese GMP

Indication:Indication 1.1 Metastatic Breast Cancer Paclitaxel for Injection is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse with

Specification:100mg

Dosage Form:Injection

Active Ingredients:Paclitaxel

Route of Administration:Subcutaneous Injection

Shelf Life:3 years

Storage:Below 25℃

Package:vial

Place of Origin:China

Qualification:Chinese GMP

Indication:Oxaliplatin for Injection

Specification:50mg, 100mg

Dosage Form:Powder

Active Ingredients:Oxaliplatin

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:Protected from light

Package:box

Qualification:Chinese GMP

Specification:1.0g

Dosage Form:Injection

Route of Administration:Intravenous Drip

Shelf Life:3 years

Storage:Sealed

Qualification:Chinese GMP

Indication:Gemcitabine Hydrochloride for Injection

Specification:0.2g, 1.0g

Dosage Form:Powder

Active Ingredients:Gemcitabine Hydrochloride

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:Protected from light

Package:box

Qualification:Chinese GMP

Indication:Vindesine Sulfate for Injection

Specification:1mg

Dosage Form:Powder

Active Ingredients:Vindesine Sulfate

Route of Administration:Intravenous Drip

Shelf Life:18 months

Storage:Protected from light

Package:nagotiable

Qualification:Chinese GMP